Serum 21-deoxycortisol and 17-hydroxypregnenolone in parents of patients with congenital adrenal hyperplasia
Tóm tắt
The response of serum 21-deoxycortisol (21-DF), 17-hydroxypregnenolone (17-OHPE), 11-deoxycortisol and Cortisol to iv ACTH, was compared in 14 adult controls and 13 sets of parents of children with adrenal 21-hydroxylase deficiency. The baseline and post stimulation concentrations of hormones were similar in controls and parents, except for those of 21-DF, which were significantly greater in heterozygotes 30 min (p<0.005), 60 min (p<0.0025) and 90 min (p< 0.005) after stimulation with ACTH. When rates of increase were determined, those of 21-DF at 30, 60 and 90 min were significantly higher in the parents. Sixteen of the 26 parents (62%) had a rate of increase of 21-DF from 0 to 60 min greater than the mean plus two standard deviations of the control group. Using this same criteria, 11 of the 13 mothers (85%) of affected children could be identified as heterozygotes. The rate of increase of 21-DF from 0 to 60 min following ACTH provides a method for the detection of some heterozygote carriers of congenital adrenal hyperplasia and may be useful particularly in the identification of female carriers.
Tài liệu tham khảo
Childs B., Grumbach M.M., Van Wyk J.J. Virilizing adrenal hyperplasia: a genetic and hormonal study. J.Clin. Invest. 35: 213, 1956.
Prader A., Anders G.J., Habich H. Zur Genetik des Kongenitalen Adrenogenitalen Syndrome. Helv. Paediatr. Acta 17: 271, 1962.
Knorr D., Bidlingmaier F., Butenandt D., Schmakenburg K., Wagner W. A test for heterozygocity in congenital adrenal hyperplasia. Pediatr. Res. 9: 681, 1975.
Lee P., Gareis F.J. Evidence for partial 21 hydroxylase deficiency among heterozygote carrier of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 41: 415, 1975.
Gutai J.P., Kowarski A.A., Migeon C.J. The detection of the heterozygote carrier for congenital virilizing adrenal hyperplasia. J. Pediatr. 90: 924, 1977.
Krensky A.M., Bongiovanni A.M., Marino J., Parks J.S., Tenore A. Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17 OH-progesterone. J. Pediatr. 90: 930, 1977.
Bongiovanni A.M. Congenital adrenal hyperplasia and related conditions. In: Stanbury J.B., Wyngaarden J.B., Fredricksen D.S. (Eds.), Metabolic basis on inherited disease. Mc Graw-Hill, New York, 1978, P. 868.
Mackler B., Haynes B., Tattoni D.S., Tippit D.F., Kelley V.C. Studies of adrenal steroid hydroxylation. 1. Purification of the microsomal 21-hydroxylase system. Arch. Biochem. Biophys. 145: 194, 1972.
Spark R.F. Simplified assessment of pituitary adrenal reserve: measurement of serum 11-deoxycortisol and Cortisol after metyrapone. Ann. Intern. Med. 75: 717, 1971.
Murphy B.E.P. Some studies of the protein binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein binding radioassay. J. Clin. Endocrinol. Metab. 27: 973, 1967.
Cleveland W.W., Nikezic M., Migeon C.J. Response to an 11 β-hydroxylase inhibitor (SU-4885) in males with adrenal hyperplasia and their parents. J. Clin. Endocrinol. Metab. 22: 281, 1962.
Bergada C.M., Rivarola M.A., Cullen M. Seventh Pan American Congress of Endocrinology, Excerpta Medica International Series 99: E 130, 1965.
Hall R., Smith P.A., Hakness RA, Smart G.A. A study of parents of patients with congenital adrenal hyperplasia: detection of the heterozygote. Proc. R. Soc. Med. 63: 1041, 1970.
Qazi Q.H., Hill J.G., Thompson M.W. Steroid studies in parents of patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 33: 23, 1971.
Levine L.S., Zachmann M., New M.I., Prader A., Pollack M.S., O’Neill G.J., Yang S.Y., Oberfield S.E., Dupont B. Genetic mapping of the 21-hydroxylase deficiency gene within the HLA linkage group. N. Engl. J. Med. 299: 911, 1978.
Strott C.A., Bermudez J.A., Lipsett M.B. Blood levels and production rate of 17-hydroxypregneno-lone in man. J. Clin. Invest. 49: 1999, 1970.
Loriaux D.L., Lipsett M.B. Radioligand assay for A5 3B hydroxysteroids. Steroids 19: 681, 1972.
Abraham G.E., Corrales P.C., Teller R.C. Radioimmunoassay of plasma 17-hydroxypregnenolone. Analy. Lett. 5: 915, 1972.
McKenna T.J., DiPietro D.L., Brown R.D., Strott C.A., Liddie G.W. Plasma 17-hydroxypregnenolone in normal subjects J. Clin. Endocrinol Metab. 39: 833, 1974.
Aedo A.R., Landgren B.M., Cekan Z., Diczfalusy E. Studies on the pattern of circulating steroids in the normal menstrual cycle. Acta Endocrinol. (Kbh.) 82: 600, 1976.